Strong China Sales Boost Q2 Results For Philips
Dutch health giant Philips reported Q2 results 22 July, showing better-than-expected sales across its medtech businesses. Strong growth in China and North America boosted the firm’s diagnosis and treatment businesses by 6% from the same period last year.
You may also be interested in...
Royal Philips is planning to sell its domestic appliance business to better focus on its strategic aims in health technology. The group made the announcement as it unveiled 2019 sales up 4.5% on a comparable basis.
Despite disappointment in its Phase III study, Roche is preparing a new trial of the antisense therapy in patients with a lower disease burden.
The German biotech inks its fifth metabolic disease collaboration as it teams up with US major Eli Lilly to develop kidney disease and diabetes assets.